AU2001265186A1 - Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions - Google Patents
Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditionsInfo
- Publication number
- AU2001265186A1 AU2001265186A1 AU2001265186A AU6518601A AU2001265186A1 AU 2001265186 A1 AU2001265186 A1 AU 2001265186A1 AU 2001265186 A AU2001265186 A AU 2001265186A AU 6518601 A AU6518601 A AU 6518601A AU 2001265186 A1 AU2001265186 A1 AU 2001265186A1
- Authority
- AU
- Australia
- Prior art keywords
- treatment
- epoxyeicosatrienoic acids
- cerebrovascular conditions
- cerebrovascular
- conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000002121 epoxyeicosatrienoic acids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20797800P | 2000-05-30 | 2000-05-30 | |
US60/207,978 | 2000-05-30 | ||
PCT/US2001/017452 WO2001091745A2 (en) | 2000-05-30 | 2001-05-30 | Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001265186A1 true AU2001265186A1 (en) | 2001-12-11 |
Family
ID=22772743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001265186A Abandoned AU2001265186A1 (en) | 2000-05-30 | 2001-05-30 | Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020077355A1 (en) |
AU (1) | AU2001265186A1 (en) |
WO (1) | WO2001091745A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003048831A (en) | 2001-08-02 | 2003-02-21 | Suntory Ltd | Composition having preventing and ameliorating action on symptom or disease caused by decrease in brain function |
FR2843026B1 (en) * | 2002-08-02 | 2006-01-06 | Goemar Lab Sa | NEW MEDICINE |
JP4522075B2 (en) * | 2003-10-29 | 2010-08-11 | サントリーホールディングス株式会社 | Composition having an effect of preventing or ameliorating symptoms or diseases caused by aging of blood vessels |
EP1765311A4 (en) * | 2004-03-16 | 2009-04-29 | Univ California | Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoids |
JP4993852B2 (en) | 2004-09-17 | 2012-08-08 | サントリーホールディングス株式会社 | Composition having a preventive or ameliorating effect on symptoms or diseases accompanied by behavioral abnormalities caused by stress |
WO2006133257A2 (en) * | 2005-06-06 | 2006-12-14 | The Regents Of The University Of California | Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy |
JP5967855B2 (en) | 2005-06-30 | 2016-08-10 | サントリーホールディングス株式会社 | Composition having an activity of reducing daytime activity and / or depressive symptoms |
ATE555656T1 (en) * | 2005-08-19 | 2012-05-15 | Univ California | USE OF VISION INHIBITORS AS ANALGESICS |
CA2671837A1 (en) * | 2006-12-18 | 2008-06-26 | F. Hoffmann-La Roche Ag | Novel use of inhibitors of soluble epoxide hydrolase |
JPWO2008081989A1 (en) | 2006-12-28 | 2010-04-30 | サントリーホールディングス株式会社 | Nerve regeneration agent |
WO2010091052A2 (en) | 2009-02-03 | 2010-08-12 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
US9056085B2 (en) | 2009-02-03 | 2015-06-16 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
US20160008342A1 (en) | 2014-06-16 | 2016-01-14 | The Regents Of The University Of California | Methods of improving cell-based therapy |
US10813894B2 (en) | 2015-02-20 | 2020-10-27 | The Regents Of The University Of California | Methods of inhibiting pain |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6916843B1 (en) * | 1999-08-11 | 2005-07-12 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-inflammatory actions of cytochrome P450 expoxygenase-derived eicosanoids |
-
2001
- 2001-05-30 WO PCT/US2001/017452 patent/WO2001091745A2/en active Application Filing
- 2001-05-30 AU AU2001265186A patent/AU2001265186A1/en not_active Abandoned
- 2001-05-30 US US09/870,425 patent/US20020077355A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001091745A3 (en) | 2002-08-29 |
US20020077355A1 (en) | 2002-06-20 |
WO2001091745A2 (en) | 2001-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001259758A1 (en) | Interleukin-1 inhibitors in the treatment of diseases | |
AU2001293553A1 (en) | Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment | |
AU2002223599A1 (en) | Pyrimidinone derivatives and their use in the treatment of atherosclerosis | |
IL155092A0 (en) | Compounds useful in the treatment of inflammatory diseases | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
AU4340700A (en) | Methods and compositions for use in the treatment of hyperlipidemia | |
AU2001234837A1 (en) | Azapeptides useful in the treatment of hepatitis c | |
AU4439401A (en) | Methods and apparatus usable with or applicable to the use of the internet | |
AU2001265186A1 (en) | Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions | |
AU2003255993A1 (en) | Diazabicyclic compounds useful in the treatment of cns and other disorders | |
AU2837301A (en) | Use of polymeric material in the treatment of hard surfaces | |
AU2001260834A1 (en) | The treatment of herpes | |
SI1197485T1 (en) | Cyclobuten-dione derivatives for use in the treatment of artherosclerosis | |
AU5056099A (en) | Compounds for use in the treatment of inflammation | |
AU2002243363A1 (en) | Use of aziridino-compounds in the treatment of immune dysfunctions | |
AU5262200A (en) | Arrangement in ventilatory treatment of the lungs | |
PT1152756E (en) | USEFUL ANTICONVULSIVE DERIVATIVES IN THE TREATMENT OF AUTISM | |
AU2003219511A1 (en) | Carnitine in the treatment of geriatric depression | |
AU2001253886A1 (en) | Methylxanthines in the diagnosis and treatment of autistic disorder | |
AU2001236929A1 (en) | Surface treatment | |
AU5565401A (en) | Materials and methods for the treatment of depression | |
AU2002210763A1 (en) | Use of 1-ebio in the treatment of bipolar disorders | |
AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
AU2002241162A1 (en) | Intimins in the prevention or treatment of infections:ii | |
AU2001254825A1 (en) | Butenoic acids derivatives and their use in the treatment of rhinitis |